Raku Co

Raku Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Raku Co (4154.TWO) as of Oct 17, 2026 is 113.74 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 39.52 % — a change of 187.78% (higher).

FCF Conversion

113.74 %

YoY

187.78%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Raku Co is 2025 113.74 % . FCF Conversion Rate (FCF/EBITDA) of Raku Co was 2024 39.52 % . It decreases by 187.78% higher compared to the previous year.

The Raku Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
5.08 TWD
Jan 1, 2019
-33.56 TWD
Jan 1, 2020
434.31 TWD
Jan 1, 2021
266.48 TWD
Jan 1, 2022
301.38 TWD
Jan 1, 2023
-44.12 TWD
Jan 1, 2024
39.52 TWD
Jan 1, 2025
113.74 TWD
The Raku Co FCF Conversion history
YEARFCF ConversionYoY
113.74 %+187.78%
39.52 %-189.58%
-44.12 %-114.64%
301.38 %+13.10%
266.48 %-38.64%
434.31 %-1,394.12%
-33.56 %-760.77%
5.08 %-95.15%
104.82 %-146.59%
-224.97 %-236.10%
165.29 %+507.23%
27.22 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Raku Co Stock analysis

What does Raku Co do? Raku Co Ltd, trading under the ticker symbol 4154 on the Singapore Exchange, is a corporate entity incorporated in Singapore with the ISIN KYG527551082. The company operates within the Consumer Staples sector, specifically focusing on the Beverages industry, although its operational scope extends significantly into health and wellness products. As of the most recent data, the organization employs a workforce of 103 individuals. Raku Co Ltd went public on July 27, 2011, marking a significant milestone in its corporate history. The company maintains an online presence through its website at https://www.kinobiotech.com/. While the specific city of operation is not explicitly detailed in available records, the company is headquartered in Singapore. The business model of Raku Co Ltd is characterized by its role as an integrated bio-nutraceutical and cosmeceutical enterprise. It engages in a comprehensive range of activities including the sale, distribution, manufacture, and development of healthcare and beauty products. The firm places a strong emphasis on product conceptualization, development, commercialization, brand marketing, and the subsequent sale and distribution of these goods. The company markets its products under several recognized brands, notably Kinohimitsu, Activa, and Xpertise. These brands serve as the primary vehicles for delivering healthcare and beauty solutions to consumers. Raku Co Ltd has established a logistical footprint that includes over two logistic and distribution centers located in Malaysia and China. This infrastructure supports its distribution network, which supplies products to a diverse range of markets across Southeast Asia. The company’s product reach extends to China, Singapore, Malaysia, Vietnam, Thailand, and Indonesia. This regional distribution strategy allows the firm to capitalize on the growing demand for bio-nutraceutical and cosmeceutical products in these economies. The integration of manufacturing, development, and distribution under one corporate umbrella enables Raku Co Ltd to maintain control over the quality and availability of its offerings. The company’s focus on both healthcare and beauty products reflects a strategic diversification within the consumer staples sector. By leveraging its brand portfolio and logistical capabilities, Raku Co Ltd aims to sustain its market position and expand its customer base across the identified regions. The company’s public listing since 2011 provides it with access to capital markets, potentially facilitating further growth and operational expansion. The employment figure of 103 suggests a lean operational structure, which may contribute to agility in product development and market response. The specific details regarding the city of operation remain unspecified, but the Singaporean incorporation and regional distribution centers highlight its strategic positioning in the Asian market. Raku Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Raku Co stock

FCF Conversion Rate (FCF/EBITDA) of Raku Co is 113.74 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Raku Co changed from 39.52 % to 113.74 %, representing a 187.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Raku Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Raku Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Raku Co

All Key Metrics — Raku Co